402 filings
Page 7 of 21
6-K
SPRC
SciSparc Ltd
29 Jun 22
SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
8:36am
6-K
SPRC
SciSparc Ltd
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
6-K
SPRC
SciSparc Ltd
9 Jun 22
SciSparc’s Board of Directors Provides Strategic Decision
8:38am
D
SPRC
SciSparc Ltd
8 Jun 22
$10M in equity / options, sold $10M, 1 investor
4:02pm
6-K
SPRC
SciSparc Ltd
2 Jun 22
Report of Foreign Private Issuer
4:30pm
6-K
SPRC
SciSparc Ltd
1 Jun 22
SciSparc to Collaborate with Polyrizon for Brain Targeting Using Intranasal Hydrogel Systems
4:11pm
6-K
SPRC
SciSparc Ltd
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
SPRC
SciSparc Ltd
26 May 22
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
8:33am
6-K
SPRC
SciSparc Ltd
24 May 22
SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment
8:31am
6-K
SPRC
SciSparc Ltd
11 May 22
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields New Patent Application for Psychedelic Combination Treatment for Binge Behaviors
1:58pm
SC 13G/A
Eide Robert J
9 May 22
SciSparc / EIDE ROBERT J ownership change
4:08pm
EFFECT
SPRC
SciSparc Ltd
4 May 22
Notice of effectiveness
12:15am
POS AM
SPRC
SciSparc Ltd
28 Apr 22
Prospectus update (post-effective amendment)
5:20pm
20-F
2021 FY
SPRC
SciSparc Ltd
Annual report (foreign)
28 Apr 22
4:16pm
6-K
SPRC
SciSparc Ltd
1 Apr 22
SciSparc Announces Closing of New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases
6:02am
6-K
SPRC
SciSparc Ltd
17 Mar 22
SciSparc Announces Positive Results from Psychedelic-Based Pre-Clinical Trial
9:06am
6-K
SPRC
SciSparc Ltd
15 Mar 22
Report of Foreign Private Issuer
7:37pm
6-K
SPRC
SciSparc Ltd
10 Mar 22
SciSparc Launches New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases
10:16am
6-K
SPRC
SciSparc Ltd
9 Mar 22
SciSparc Enters Collaboration for the Development of Innovative Psychedelic-Based Pharmaceuticals
10:59am
6-K
SPRC
SciSparc Ltd
22 Feb 22
Report of Foreign Private Issuer
9:05am